cyc 202 has been researched along with Cancer of Skin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coelho, SG; Hearing, VJ; Kaneko, Y; Katayama, I; Kawaguchi, M; Kawakami, Y; Nakamura, K; Namiki, T; Tanemura, A; Valencia, JC; Vieira, WD; Yaguchi, T; Yin, L; Yokozeki, H | 1 |
| Coppola, D; Mohapatra, S; Pledger, WJ; Riker, AI | 1 |
2 other study(ies) available for cyc 202 and Cancer of Skin
| Article | Year |
|---|---|
NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.
Topics: Aged; Animals; Cell Growth Processes; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Gene Amplification; Humans; Male; Melanoma; Mice; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; PTEN Phosphohydrolase; Purines; Roscovitine; Signal Transduction; Skin Neoplasms | 2015 |
Roscovitine inhibits differentiation and invasion in a three-dimensional skin reconstruction model of metastatic melanoma.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Humans; Melanoma; Models, Biological; Neoplasm Invasiveness; Protein Kinase Inhibitors; Purines; Roscovitine; Skin Neoplasms; Tissue Culture Techniques | 2007 |